<?xml version="1.0" encoding="UTF-8"?>
<html lang="en" dir="ltr" xmlns="http://www.w3.org/1999/xhtml">
 <head prefix="og: http://ogp.me/ns# article: http://ogp.me/ns/article# book: http://ogp.me/ns/book#"> 
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/> 
  <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=3, minimum-scale=1, user-scalable=yes"/> 
  <meta name="type" content="article"/>
  <meta name="HW.identifier" content="/biorxiv/early/2020/04/10/2020.04.08.032763.atom"/>
  <meta name="HW.pisa" content="biorxiv;2020.04.08.032763v2"/>
  <meta name="DC.Format" content="text/html"/>
  <meta name="DC.Language" content="en"/>
  <meta name="DC.Title" content="Structural Basis for the Inhibition of the RNA-Dependent RNA Polymerase from SARS-CoV-2 by Remdesivir"/>
  <meta name="DC.Identifier" content="10.1101/2020.04.08.032763"/>
  <meta name="DC.Date" content="2020-04-10"/>
  <meta name="DC.Publisher" content="Cold Spring Harbor Laboratory"/>
  <meta name="DC.Rights" content="© 2020, Posted by Cold Spring Harbor Laboratory. This pre-print is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), CC BY-NC 4.0, as described at http://creativecommons.org/licenses/by-nc/4.0/"/>
  <meta name="DC.AccessRights" content="restricted"/>
  <meta name="DC.Description" content="The pandemic of Corona Virus Disease 2019 (COVID-19) caused by SARS-CoV-2 has become a global crisis. The replication of SARS-CoV-2 requires the viral RNA-dependent RNA polymerase (RdRp), a direct target of the antiviral drug, Remdesivir. Here we report the structure of the SARS-CoV-2 RdRp either in the apo form or in complex with a 50-base template-primer RNA and Remdesivir at a resolution range of 2.5-2.8 Å. The complex structure reveals that the partial double-stranded RNA template is inserted into the central channel of the RdRp where Remdesivir is incorporated into the first replicated base pair and terminates the chain elongation. Our structures provide critical insights into the working mechanism of viral RNA replication and a rational template for drug design to combat the viral infection. ### Competing Interest Statement The authors have declared no competing interest."/>
  <meta name="DC.Contributor" content="Wanchao Yin"/>
  <meta name="DC.Contributor" content="Chunyou Mao"/>
  <meta name="DC.Contributor" content="Xiaodong Luan"/>
  <meta name="DC.Contributor" content="Dan-Dan Shen"/>
  <meta name="DC.Contributor" content="Qingya Shen"/>
  <meta name="DC.Contributor" content="Haixia Su"/>
  <meta name="DC.Contributor" content="Xiaoxi Wang"/>
  <meta name="DC.Contributor" content="Fulai Zhou"/>
  <meta name="DC.Contributor" content="Wenfeng Zhao"/>
  <meta name="DC.Contributor" content="Minqi Gao"/>
  <meta name="DC.Contributor" content="Shenghai Chang"/>
  <meta name="DC.Contributor" content="Yuan-Chao Xie"/>
  <meta name="DC.Contributor" content="Guanghui Tian"/>
  <meta name="DC.Contributor" content="He-Wei Jiang"/>
  <meta name="DC.Contributor" content="Sheng-Ce Tao"/>
  <meta name="DC.Contributor" content="Jingshan Shen"/>
  <meta name="DC.Contributor" content="Yi Jiang"/>
  <meta name="DC.Contributor" content="Hualiang Jiang"/>
  <meta name="DC.Contributor" content="Yechun Xu"/>
  <meta name="DC.Contributor" content="Shuyang Zhang"/>
  <meta name="DC.Contributor" content="Yan Zhang"/>
  <meta name="DC.Contributor" content="H. Eric Xu"/>
  <meta name="article:published_time" content="2020-04-10"/>
  <meta name="article:section" content="New Results"/>
  <meta name="citation_title" content="Structural Basis for the Inhibition of the RNA-Dependent RNA Polymerase from SARS-CoV-2 by Remdesivir"/>
  <meta name="citation_abstract" lang="en" content="&lt;;p&gt;;The pandemic of Corona Virus Disease 2019 (COVID-19) caused by SARS-CoV-2 has become a global crisis. The replication of SARS-CoV-2 requires the viral RNA-dependent RNA polymerase (RdRp), a direct target of the antiviral drug, Remdesivir. Here we report the structure of the SARS-CoV-2 RdRp either in the apo form or in complex with a 50-base template-primer RNA and Remdesivir at a resolution range of 2.5-2.8 Å. The complex structure reveals that the partial double-stranded RNA template is inserted into the central channel of the RdRp where Remdesivir is incorporated into the first replicated base pair and terminates the chain elongation. Our structures provide critical insights into the working mechanism of viral RNA replication and a rational template for drug design to combat the viral infection.&lt;;/p&gt;;"/>
  <meta name="citation_journal_title" content="bioRxiv"/>
  <meta name="citation_publisher" content="Cold Spring Harbor Laboratory"/>
  <meta name="citation_publication_date" content="2020/01/01"/>
  <meta name="citation_mjid" content="biorxiv;2020.04.08.032763v2"/>
  <meta name="citation_id" content="2020.04.08.032763v2"/>
  <meta name="citation_public_url" content="https://www.biorxiv.org/content/10.1101/2020.04.08.032763v2"/>
  <meta name="citation_abstract_html_url" content="https://www.biorxiv.org/content/10.1101/2020.04.08.032763v2.abstract"/>
  <meta name="citation_full_html_url" content="https://www.biorxiv.org/content/10.1101/2020.04.08.032763v2.full"/>
  <meta name="citation_pdf_url" content="https://www.biorxiv.org/content/biorxiv/early/2020/04/10/2020.04.08.032763.full.pdf"/>
  <meta name="citation_doi" content="10.1101/2020.04.08.032763"/>
  <meta name="citation_section" content="New Results"/>
  <meta name="citation_firstpage" content="2020.04.08.032763"/>
  <meta name="citation_author" content="Wanchao Yin"/>
  <meta name="citation_author_institution" content="Shanghai Institute of Materia Medica;"/>
  <meta name="citation_author_email" content="wcyin@simm.ac.cn"/>
  <meta name="citation_author_orcid" content="http://orcid.org/0000-0002-6889-4907"/>
  <meta name="citation_author" content="Chunyou Mao"/>
  <meta name="citation_author_institution" content="Zhejiang University School of Medicine;"/>
  <meta name="citation_author_email" content="maochunyou@zju.edu.cn"/>
  <meta name="citation_author" content="Xiaodong Luan"/>
  <meta name="citation_author_institution" content="Tsinghua University;"/>
  <meta name="citation_author_email" content="lxd18@mails.tsinghua.edu.cn"/>
  <meta name="citation_author" content="Dan-Dan Shen"/>
  <meta name="citation_author_institution" content="Zhejiang University School of Medicine;"/>
  <meta name="citation_author_email" content="0918570@zju.edu.cn"/>
  <meta name="citation_author" content="Qingya Shen"/>
  <meta name="citation_author_institution" content="Zhejiang University School of Medicine;"/>
  <meta name="citation_author_email" content="shen_qingya@zju.edu.cn"/>
  <meta name="citation_author" content="Haixia Su"/>
  <meta name="citation_author_institution" content="Shanghai Institute of Materia Medica;"/>
  <meta name="citation_author_email" content="201628012342089@simm.ac.cn"/>
  <meta name="citation_author" content="Xiaoxi Wang"/>
  <meta name="citation_author_institution" content="Shanghai Institute of Materia Medica Chinese Academy of Sciences;"/>
  <meta name="citation_author_email" content="xiaoxiw@simm.ac.cn"/>
  <meta name="citation_author" content="Fulai Zhou"/>
  <meta name="citation_author_institution" content="Shanghai Institute of Materia Medica;"/>
  <meta name="citation_author_email" content="zhouflyj@yeah.net"/>
  <meta name="citation_author" content="Wenfeng Zhao"/>
  <meta name="citation_author_institution" content="Shanghai Institute of Materia Medica;"/>
  <meta name="citation_author_email" content="cpuzwf@126.com"/>
  <meta name="citation_author" content="Minqi Gao"/>
  <meta name="citation_author_institution" content="Wuxi Biortus Biosciences Co. Ltd;"/>
  <meta name="citation_author_email" content="mgao@wuxibiortus.com"/>
  <meta name="citation_author" content="Shenghai Chang"/>
  <meta name="citation_author_institution" content="Zhejiang University School of Medicine;"/>
  <meta name="citation_author_email" content="changshenghai@zju.edu.cn"/>
  <meta name="citation_author" content="Yuan-Chao Xie"/>
  <meta name="citation_author_institution" content="Shanghai Institute of Materia Medica;"/>
  <meta name="citation_author_email" content="xieyuanchao@simm.ac.cn"/>
  <meta name="citation_author" content="Guanghui Tian"/>
  <meta name="citation_author_institution" content="Shanghai Institute of Materia Medica;"/>
  <meta name="citation_author_email" content="guanghui.tian@vigonvita.cn"/>
  <meta name="citation_author" content="He-Wei Jiang"/>
  <meta name="citation_author_institution" content="Shanghai Jiao Tong University;"/>
  <meta name="citation_author_email" content="jhw622@sjtu.edu.cn"/>
  <meta name="citation_author" content="Sheng-Ce Tao"/>
  <meta name="citation_author_institution" content="Shanghai Jiao Tong University;"/>
  <meta name="citation_author_email" content="taosc@sjtu.edu.cn"/>
  <meta name="citation_author" content="Jingshan Shen"/>
  <meta name="citation_author_institution" content="Shanghai Institute of Materia Medica;"/>
  <meta name="citation_author_email" content="shenjingshan@simm.ac.cn"/>
  <meta name="citation_author" content="Yi Jiang"/>
  <meta name="citation_author_institution" content="Shanghai Institute of Materia Medica Chinese Academy of Sciences;"/>
  <meta name="citation_author_email" content="yijiang@simm.ac.cn"/>
  <meta name="citation_author" content="Hualiang Jiang"/>
  <meta name="citation_author_institution" content="Shanghai Institute of Materia Medica;"/>
  <meta name="citation_author_email" content="hljiang@simm.ac.cn"/>
  <meta name="citation_author" content="Yechun Xu"/>
  <meta name="citation_author_institution" content="Shanghai Institute of Materia Medica;"/>
  <meta name="citation_author_email" content="ycxu@simm.ac.cn"/>
  <meta name="citation_author" content="Shuyang Zhang"/>
  <meta name="citation_author_institution" content="Department of Cardiology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, No. 1 Shuaifuyuan, Beijing 100730, China"/>
  <meta name="citation_author_email" content="shuyangzhang103@nrdrs.org"/>
  <meta name="citation_author" content="Yan Zhang"/>
  <meta name="citation_author_institution" content="Zhejiang University School of Medicine;"/>
  <meta name="citation_author_email" content="zhang_yan@zju.edu.cn"/>
  <meta name="citation_author" content="H. Eric Xu"/>
  <meta name="citation_author_institution" content="Shanghai Institute of Materia Medica;"/>
  <meta name="citation_author_email" content="eric.xu@simm.ac.cn"/>
  <meta name="citation_author_orcid" content="http://orcid.org/0000-0002-6829-8144"/>
  <meta name="twitter:title" content="Structural Basis for the Inhibition of the RNA-Dependent RNA Polymerase from SARS-CoV-2 by Remdesivir"/>
  <meta name="twitter:site" content="@biorxivpreprint"/>
  <meta name="twitter:card" content="summary"/>
  <meta name="twitter:image" content="https://www.biorxiv.org/sites/default/files/images/biorxiv_logo_homepage7-5-small.png"/>
  <meta name="twitter:description" content="The pandemic of Corona Virus Disease 2019 (COVID-19) caused by SARS-CoV-2 has become a global crisis. The replication of SARS-CoV-2 requires the viral RNA-dependent RNA polymerase (RdRp), a direct target of the antiviral drug, Remdesivir. Here we report the structure of the SARS-CoV-2 RdRp either in the apo form or in complex with a 50-base template-primer RNA and Remdesivir at a resolution range of 2.5-2.8 Å. The complex structure reveals that the partial double-stranded RNA template is inserted into the central channel of the RdRp where Remdesivir is incorporated into the first replicated base pair and terminates the chain elongation. Our structures provide critical insights into the working mechanism of viral RNA replication and a rational template for drug design to combat the viral infection. ### Competing Interest Statement The authors have declared no competing interest."/>
  <meta name="og-title" property="og:title" content="Structural Basis for the Inhibition of the RNA-Dependent RNA Polymerase from SARS-CoV-2 by Remdesivir"/>
  <meta name="og-url" property="og:url" content="https://www.biorxiv.org/content/10.1101/2020.04.08.032763v2"/>
  <meta name="og-site-name" property="og:site_name" content="bioRxiv"/>
  <meta name="og-description" property="og:description" content="The pandemic of Corona Virus Disease 2019 (COVID-19) caused by SARS-CoV-2 has become a global crisis. The replication of SARS-CoV-2 requires the viral RNA-dependent RNA polymerase (RdRp), a direct target of the antiviral drug, Remdesivir. Here we report the structure of the SARS-CoV-2 RdRp either in the apo form or in complex with a 50-base template-primer RNA and Remdesivir at a resolution range of 2.5-2.8 Å. The complex structure reveals that the partial double-stranded RNA template is inserted into the central channel of the RdRp where Remdesivir is incorporated into the first replicated base pair and terminates the chain elongation. Our structures provide critical insights into the working mechanism of viral RNA replication and a rational template for drug design to combat the viral infection. ### Competing Interest Statement The authors have declared no competing interest."/>
  <meta name="og-type" property="og:type" content="article"/>
  <meta name="og-image" property="og:image" content="https://www.biorxiv.org/sites/default/files/images/biorxiv_logo_homepage7-5-small.png"/>
  <meta name="citation_date" content="2020-04-10"/> 
  <meta name="description" content="bioRxiv - the preprint server for biology, operated by Cold Spring Harbor Laboratory, a research and educational institution"/>
  <meta name="generator" content="Drupal 7 (http://drupal.org)"/> 
  <title>Structural Basis for the Inhibition of the RNA-Dependent RNA Polymerase from SARS-CoV-2 by Remdesivir | bioRxiv</title> 
 </head>
 <body class="html not-front not-logged-in page-node page-node- page-node-1238554 node-type-highwire-article context-content hw-default-jcode-biorxiv hw-article-category-new-results"> 
  <div class="article abstract-view ">
   <span class="highwire-journal-article-marker-start"/>
   <div class="section abstract" id="abstract-1">
    <h2>Abstract</h2>
    <p id="p-2">The pandemic of Corona Virus Disease 2019 (COVID-19) caused by SARS-CoV-2 has become a global crisis. The replication of SARS-CoV-2 requires the viral RNA-dependent RNA polymerase (RdRp), a direct target of the antiviral drug, Remdesivir. Here we report the structure of the SARS-CoV-2 RdRp either in the apo form or in complex with a 50-base template-primer RNA and Remdesivir at a resolution range of 2.5-2.8 Å. The complex structure reveals that the partial double-stranded RNA template is inserted into the central channel of the RdRp where Remdesivir is incorporated into the first replicated base pair and terminates the chain elongation. Our structures provide critical insights into the working mechanism of viral RNA replication and a rational template for drug design to combat the viral infection.</p>
   </div>
   <h3>Competing Interest Statement</h3>
   <p id="p-3">The authors have declared no competing interest.</p>
   <div class="section fn-group" id="fn-group-1">
    <h2>Footnotes</h2>
    <ul>
     <li class="fn-update fn-group-summary-of-updates" id="fn-1">
      <p id="p-4">In this revision, we have included PDB and map files for both the apo and Remdesivir bound structures for immediate download by readers.</p>
     </li>
    </ul>
   </div>
   <span class="highwire-journal-article-marker-end"/>
  </div>
 </body>
</html>
